Lyell Immunopharma, Inc.LYELNASDAQ
Loading
Cash generated from core business operations
Latest
$-150.02M
↓ 18% vs avg
Percentile
P67
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-127.62M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-150.02M | +7.6% |
| 2024 | $-162.39M | +0.8% |
| 2023 | $-163.69M | +3.5% |
| 2022 | $-169.56M | -34.3% |
| 2021 | $-126.25M | +21.5% |
| 2020 | $-160.87M | -507.5% |
| 2019 | $39.47M | - |